RE: NAV 113p and y/end 2022 NAV has increased "significantly"3 Apr 2023 09:28
NAV up when PDS has tanked?
Covering costs? Proaxis loan?. No value guidence at all.
Glycotest a 1.4m CL from Fosun - terms? Have they paid their last investment tranche? Why no RNS? Why no progress news? 3 year delay and counting. Now we are in bio and funding weakness zone - how will this proceed - assuming trials are eventually ok?
"We have seen a 'heads down' period - certainly have.
We have 23 investments, virtually no news on any - save PDS that has tanked - and a boast about a 300k trading profit.
NAV is meaningless - start managing and creating value and this year, everyone has been asleep.
V poor update